Details for 2014855074

Up to date per 03.04.2026

Actions

Title / Product Name

VERWENDUNG VON SEMAPHORIN-4D-BINDUNGSMOLEKÜLEN ZUR BEHANDLUNG NEURODEGENERATIVER ERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014855074

EP Publication Number

3060252

E-Number

1211511

Language

PCT Number

US14061592

Publication Date

31.08.2016 A

11.12.2019 B1

Registration Date

11.12.2019

AT Publication Date

15.12.2019

Application Date

21.10.2014

Registration Number

Priorities

21.10.2013

201361893814 P

14.04.2014

201461979384 P

16.06.2014

201462012805 P

IPC

A61K 39/395 20060101AFI20170504BHEP

Maximum Duration of Protection

21.10.2034

Owner

Vaccinex, Inc.1895 Mt. Hope Avenue Rochester, NY 14620US

Representative

Dipl.Ing. Dr. techn. Elisabeth SchoberFlorianigasse 26/21080 WienAT

Inventor

SMITH, Ernest S.1525 Clover Street Rochester New York 14610US

ZAUDERER, Maurice44 Woodland Road Pittsford New York 14534US

BOWERS, William J.465 Trailwood Court Webster New York 14580US

JONASON, Alan32 Eastview Terrace Pittsford New York 14534US

Information about Fees